Previous Close | 0.0169 |
Open | 0.0169 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0169 - 0.0169 |
52 Week Range | 0.0090 - 0.4345 |
Volume | |
Avg. Volume | 2,483 |
Market Cap | 678,143 |
Beta (5Y Monthly) | 0.90 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0700 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Mar 08, 2016 |
1y Target Est | N/A |
Canntab Therapeutics Limited (CSE:PILL)(OTCQB:CTABF)(FRA:TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is providing an update on several matters impacting the Company.